LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation

Grace E Kim1, Jenna L Ross2, Chaoqin Xie3

  • 1Department of Cellular and Molecular Physiology, Yale University, New Haven, CT 06520, USA.

Cardiovascular Research
|September 18, 2015
PubMed
Abstract

Insights

Liver kinase B1 (LKB1) deletion in mice causes early atrial electrical defects, impacting channel expression and conduction before fibrosis and atrial fibrillation (AF) develop. LKB1 is crucial for normal atrial development and function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Electrophysiology

Background:

  • Liver kinase B1 (LKB1) is a key kinase activating AMP-activated protein kinase (AMPK).
  • LKB1 deficiency in mice results in cardiomyopathy and atrial fibrillation (AF).
  • The role of LKB1 in early atrial development and electrophysiology is not well understood.

Purpose of the Study:

  • To investigate the impact of cardiomyocyte-specific LKB1 deletion on atrial channel expression.
  • To determine the effects of LKB1 deletion on atrial electrophysiological function in a mouse model.
  • To elucidate the role of LKB1 in early atrial biology.

Main Methods:

  • Utilized a cardiomyocyte-specific LKB1 knockout mouse model (αMHC-Cre LKB1(fl/fl)).
  • Conducted gene expression analysis, histology, and echocardiography.
  • Performed in vitro patch-clamp, ex vivo optical mapping, and in vivo ECG recordings.

Main Results:

  • Early defects in atrial depolarization, Nav1.5, and Cx40 expression were observed in LKB1-deficient neonatal mice.
  • Reduced inward sodium current density in neonatal atrial myocytes.
  • Development of atrial fibrosis, AF, and impaired interatrial conduction by adulthood.

Conclusions:

  • LKB1 deletion leads to early atrial channel and electrophysiological defects.
  • These defects precede atrial remodeling, fibrosis, and AF onset.
  • LKB1 is essential for normal atrial growth and electrophysiological integrity.

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
989
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
812
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K